Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Cash from Financing Activities (2020 - 2025)

KORU Medical Systems has reported Cash from Financing Activities over the past 10 years, most recently at -$264908.0 for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$264908.0 for Q4 2025, down 22.8% from a year ago — trailing twelve months through Dec 2025 was -$221350.0 (up 10.94% YoY), and the annual figure for FY2025 was -$221350.0, up 10.94%.
  • Cash from Financing Activities for Q4 2025 was -$264908.0 at KORU Medical Systems, down from $396330.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for KRMD hit a ceiling of $2.2 million in Q1 2021 and a floor of -$264908.0 in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was -$169581.5 (2023), compared with a mean of $114800.8.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 119.42% in 2021 and later plummeted 32154.12% in 2022.
  • KORU Medical Systems' Cash from Financing Activities stood at -$133714.0 in 2021, then dropped by 8.89% to -$145603.0 in 2022, then fell by 22.49% to -$178355.0 in 2023, then fell by 20.95% to -$215716.0 in 2024, then dropped by 22.8% to -$264908.0 in 2025.
  • The last three reported values for Cash from Financing Activities were -$264908.0 (Q4 2025), $396330.0 (Q3 2025), and -$191964.0 (Q2 2025) per Business Quant data.